Abstract

Objectives: The aims of this study are to investigate the prevalence of occult hepatitis B virus infection among patients with cryptogenic cirrhosis and to analyze the relationship between surface protein variability and occult hepatitis B virus infection, which may be related to the pathogenesis of occult hepatitis B virus infection in cryptogenic cirrhosis. Occult hepatitis B virus infection is a well-recognized clinical entity characterized by the detection of hepatitis B virus DNA in serum and/or liver in the absence of detectable hepatitis B virus surface antigen, with or without any serological markers of a past infection. Methods: Sera from patients with cryptogenic chronic liver disease were tested for hepatitis B virus DNA using both real-time and nested PCR. In the detected hepatitis B virus DNA samples, the surface gene was analyzed for mutations. Results: Hepatitis B virus DNA was detected in 38% of patients, all of whom had a viral load below 10,000 copies/mL. All hepatitis B virus belonged to genotype D. There were no significant associations between occult hepatitis B virus infection status and age, gender, ALT/AST levels, viral load or serologic markers of previous hepatitis B virus infection. There were 14 mutations found in 5 patients; 6 were in the major hydrophilic region, of which 4 were Y134F assigning for the "a" determinant region. All patients who acquired Y134F contained S207R (within HLA-A2-restricted CTL epitope) as a combination. Conclusion: Hepatitis B virus surface antigen variants may arise as a result of natural selection to evade the immune surveillance of the infected host, and subsequently may go undetected by conventional hepatitis B virus surface antigen screening tests. Etiological diagnosis of cryptogenic cirrhosis is significantly underestimated with current serology testing methods alone.

Keywords

Publication details

DOI
10.5001/omj.2014.23
Journal
Oman Medical Journal
Publisher
Oman Medical Specialty Board
Open access
Gold open access

Cite this article

APA 7

Anvari, F. A., Alavian, S. M., Norouzi, M., Mahabadi, M., & Jazayeri, S. M. (2014). Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran. Oman Medical Journal. https://doi.org/10.5001/omj.2014.23

MLA 9

Anvari, Fatemeh Akhavan, et al. "Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran." Oman Medical Journal, 2014. https://doi.org/10.5001/omj.2014.23.

Chicago (author–date)

Anvari, Fatemeh Akhavan, Seyed Moayyed Alavian, Mehdi Norouzi, Mostafa Mahabadi, and Seyed Mohammad Jazayeri. 2014. "Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran." Oman Medical Journal. https://doi.org/10.5001/omj.2014.23.

Harvard

Anvari, F. A., Alavian, S. M., Norouzi, M., Mahabadi, M. and Jazayeri, S. M. (2014) 'Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran', Oman Medical Journal. doi:10.5001/omj.2014.23.

Vancouver

Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran. Oman Medical Journal. 2014. doi:10.5001/omj.2014.23

IEEE

F. A. Anvari, S. M. Alavian, M. Norouzi, M. Mahabadi, and S. M. Jazayeri, "Prevalence and Molecular Analysis of Occult Hepatitis B Virus Infection Isolated in a Sample of Cryptogenic Cirrhosis Patients in Iran," Oman Medical Journal, 2014, doi: 10.5001/omj.2014.23.